ArticlePharmaceutics2018

Designing a Formulation of the Nootropic Drug Aniracetam Using 2-Hydroxypropyl-β-Cyclodextrin Suitable for Parenteral Administration.

Sebastian D Goldsmith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.